ANCHOR CRC: Results From a Single-Arm , Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF(V600E)-Mutant Metastatic Colorectal Cancer

by on 9 d'octubre de 2023 with No hi ha comentaris
  • Van Cutsem, E., Taieb, J., Yaeger, R., Yoshino, T., Grothey, A., Maiello, E., . . . Tabernero, J. (2023). ANCHOR CRC: Results From a Single-Arm , Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated BRAF(V600E)-Mutant Metastatic Colorectal Cancer. Journal of Clinical Oncology, 41(14), 2628-+. https://doi.org/10.1200/jco.22.01693

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *